ArticleAdvances in therapy2017

Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis.

Nicholas J Vogelzang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.